Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
Clinical trial NCT04687020 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04687020
- Sponsor
- NS Pharma, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2032-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.